Senior Product Manager AI & Data Analytics
Relevant for
FixVUE, InSituPlex
Description Moritz Widmaier, PhD, guides you through the different questions and how to solve them: What’s the most relevant assay for my study? In which tissues is my system expressed? Is there a change in the TME after treatment? How can my biomarker be easily transferred to clinical practice?
Moritz will drill his way through whatever intellectual challenge you’ll put in front of him. He previously perforated biochemistry, image analysis, data science, immuno-oncology biomarkers, product management/ownership. He’ll condense the best of our ideas into a coherent roadmap. His product backlog will guide us towards our vision one step at a time.
Senior Product Manager AI & Data Analytics
Relevant for
FlexVUE, InSituPlex
Description Moritz Widmaier, PhD, guides you through the different questions and how to solve them: What’s the most relevant assay for my study? In which tissues is my system expressed? Is there a change in the TME after treatment? How can my biomarker be easily transferred to clinical practice?
Moritz will drill his way through whatever intellectual challenge you’ll put in front of him. He previously perforated biochemistry, image analysis, data science, immuno-oncology biomarkers, product management/ownership. He’ll condense the best of our ideas into a coherent roadmap. His product backlog will guide us towards our vision one step at a time.
Moritz will drill his way through whatever intellectual challenge you’ll put in front of him. He previously perforated biochemistry, image analysis, data science, immuno-oncology biomarkers, product management/ownership. He’ll condense the best of our ideas into a coherent roadmap. His product backlog will guide us towards our vision one step at a time.
Senior Director Scientific Brand Strategy
Relevant for
FlexVUE, InSituPlex
Description Moritz Widmaier, PhD, guides you through the different questions and how to solve them: What’s the most relevant assay for my study? In which tissues is my system expressed? Is there a change in the TME after treatment? How can my biomarker be easily transferred to clinical practice?
Moritz will drill his way through whatever intellectual challenge you’ll put in front of him. He previously perforated biochemistry, image analysis, data science, immuno-oncology biomarkers, product management/ownership. He’ll condense the best of our ideas into a coherent roadmap. His product backlog will guide us towards our vision one step at a time.
Associate Director, Scientific Affairs Ultivue; Chief Science Officer, OracleBio
Relevant for
FixVUE, InSituPlex
Description Moritz Widmaier, PhD, guides you through the different questions and how to solve them: What’s the most relevant assay for my study? In which tissues is my system expressed? Is there a change in the TME after treatment? How can my biomarker be easily transferred to clinical practice?
Moritz will drill his way through whatever intellectual challenge you’ll put in front of him. He previously perforated biochemistry, image analysis, data science, immuno-oncology biomarkers, product management/ownership. He’ll condense the best of our ideas into a coherent roadmap. His product backlog will guide us towards our vision one step at a time.
Lorcan is an image analysis expert who previously spent 10 years in the pharmaceutical industry as a group leader (Organon, Schering-Plough, Merck & Co.). He led a group responsible for performing histology, immunohistochemistry / image analysis and he has considerable experience in developing translational biomarker strategies for projects across various therapeutic areas. He is a Prince 2® qualified project manager and has extensive experience in study management.
Senior Manager, FAS, North America
Relevant for
FlexVUE, InSituPlex
Description Moritz Widmaier, PhD, guides you through the different questions and how to solve them: What’s the most relevant assay for my study? In which tissues is my system expressed? Is there a change in the TME after treatment? How can my biomarker be easily transferred to clinical practice?
Moritz will drill his way through whatever intellectual challenge you’ll put in front of him. He previously perforated biochemistry, image analysis, data science, immuno-oncology biomarkers, product management/ownership. He’ll condense the best of our ideas into a coherent roadmap. His product backlog will guide us towards our vision one step at a time.
Principal Software Engineer
Relevant for
FixVUE, FlexVUE, InSituPlex, U-VUE
Description Moritz Widmaier, PhD, guides you through the different questions and how to solve them: What’s the most relevant assay for my study? In which tissues is my system expressed? Is there a change in the TME after treatment? How can my biomarker be easily transferred to clinical practice?
Moritz will drill his way through whatever intellectual challenge you’ll put in front of him. He previously perforated biochemistry, image analysis, data science, immuno-oncology biomarkers, product management/ownership. He’ll condense the best of our ideas into a coherent roadmap. His product backlog will guide us towards our vision one step at a time.
Associate Director Scientific Affairs
Relevant for
FlexVUE, InSituPlex
Description Moritz Widmaier, PhD, guides you through the different questions and how to solve them: What’s the most relevant assay for my study? In which tissues is my system expressed? Is there a change in the TME after treatment? How can my biomarker be easily transferred to clinical practice?
Moritz will drill his way through whatever intellectual challenge you’ll put in front of him. He previously perforated biochemistry, image analysis, data science, immuno-oncology biomarkers, product management/ownership. He’ll condense the best of our ideas into a coherent roadmap. His product backlog will guide us towards our vision one step at a time.
Senior Scientists, Product Development
Relevant for
FlexVUE, InSituPlex
Description Moritz Widmaier, PhD, guides you through the different questions and how to solve them: What’s the most relevant assay for my study? In which tissues is my system expressed? Is there a change in the TME after treatment? How can my biomarker be easily transferred to clinical practice?
Moritz will drill his way through whatever intellectual challenge you’ll put in front of him. He previously perforated biochemistry, image analysis, data science, immuno-oncology biomarkers, product management/ownership. He’ll condense the best of our ideas into a coherent roadmap. His product backlog will guide us towards our vision one step at a time.
Presented at: SITC 2021
Relevant for
Collaboration, FixVUE, Imaging mass cytometry, InSituPlex
Description Moritz Widmaier, PhD, guides you through the different questions and how to solve them: What’s the most relevant assay for my study? In which tissues is my system expressed? Is there a change in the TME after treatment? How can my biomarker be easily transferred to clinical practice?
Andrew A. Quong, Jordan Nieto, Derek Quong, Amanda Esch, Mael Manesse, Gourab Chatterjee, Devan Fleury, Keith A. Wharton Jr,Kirsteen H. Maclean, Mark Rees, Jeppe Thagaard, Fabian Schneider, Dan Winkowski and James Mansfield.
Presented at: SITC 2021
Relevant for
FixVUE, InSituPlex
Description Moritz Widmaier, PhD, guides you through the different questions and how to solve them: What’s the most relevant assay for my study? In which tissues is my system expressed? Is there a change in the TME after treatment? How can my biomarker be easily transferred to clinical practice?
Andrew A. Quong, Jordan Nieto, Derek Quong, Amanda Esch, Mael Manesse, Gourab Chatterjee, Devan Fleury, Keith A. Wharton Jr,Kirsteen H. Maclean, Mark Rees, Jeppe Thagaard, Fabian Schneider, Dan Winkowski and James Mansfield.
Presented at: SITC 2021
Relevant for
Collaboration, FixVUE, InSituPlex
Description Moritz Widmaier, PhD, guides you through the different questions and how to solve them: What’s the most relevant assay for my study? In which tissues is my system expressed? Is there a change in the TME after treatment? How can my biomarker be easily transferred to clinical practice?
Relevant for
FixVUE, InSituPlex, U-VUE
Description Overview highlighting the use of the InSituPlex® (ISP) a novel, robust mIF assay technology reliant on conjugating DNA barcodes to antibodies and using sequence-specific DNA-DNA hybridization tolabel antibodies for spatial profiling of immuno-oncology targets in FFPE tumor tissue
Senior Field Applications Scientist, Ultivue
Relevant for
FixVUE, InSituPlex
Description Moritz Widmaier, PhD, guides you through the different questions and how to solve them: What’s the most relevant assay for my study? In which tissues is my system expressed? Is there a change in the TME after treatment? How can my biomarker be easily transferred to clinical practice?
Moritz will drill his way through whatever intellectual challenge you’ll put in front of him. He previously perforated biochemistry, image analysis, data science, immuno-oncology biomarkers, product management/ownership. He’ll condense the best of our ideas into a coherent roadmap. His product backlog will guide us towards our vision one step at a time.
Associate Director, Scientific Affairs; Senior Scientist, Visiopharm
Relevant for
Collaboration, FixVUE, InSituPlex
Description Moritz Widmaier, PhD, guides you through the different questions and how to solve them: What’s the most relevant assay for my study? In which tissues is my system expressed? Is there a change in the TME after treatment? How can my biomarker be easily transferred to clinical practice?
Moritz will drill his way through whatever intellectual challenge you’ll put in front of him. He previously perforated biochemistry, image analysis, data science, immuno-oncology biomarkers, product management/ownership. He’ll condense the best of our ideas into a coherent roadmap. His product backlog will guide us towards our vision one step at a time.
Dr. Fabian Schneider is part of Visiopharm’s R&D and Product Management team, responsible for phenotyping products as well as service projects for custom APP development. Fabian has over 10 years of international experience in cancer biology and immuno-oncology, working in academic research labs, clinical research teams and computational pathology groups in both academia and biopharma. Fabian received his Dr phil. nat. in Cell Biology in 2011 from the Johan Wolfgang Goethe University Frankfurt, Germany.
Relevant for
Collaboration, FixVUE, InSituPlex
Description We describe the potential of accurate cellular phenotyping using the InSituPlex technology with fast whole-slide scanning using ZEISS Axioscan 7, an automated slide scanning system for fluorescence and transmitted light applications with modern cameras, a sophisticated focusing method and a powerful imaging software. The compounded effect of integrating these technologies can significantly improve the throughput of immuno-oncology research.
Catherine Benson, Keith Wharton, Gourab Chatterjee, Markus Neumann, Volker Döring and Maël Manesse
Biomarkers
5814
The power of data analytics in biomarker programs
